A phase II study of weekly low-dose paclitaxel plus 24-hour infusion of cisplatin as first-line chemotherapy for metastatic breast cancer (MBC)

被引：0
|
作者：
Shen, Y. [1 ]
Hsu, C. [1 ]
Kuo, S. [1 ]
Lu, Y. [1 ]
Lin, C. [1 ]
Huang, C. [1 ]
Cheng, A. [1 ]
机构：
[1] Natl Taiwan Univ Hosp, Taipei, Taiwan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1100
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase II Study of Low-dose Everolimus Plus Weekly Cisplatin and 24-hour Infusion of High-dose 5-fluorouracil and Leucovorin for First-line Treatment of Metastatic or Recurrent Gastric Cancers
    Yeh, K.
    Shen, Y. C.
    Li, C. P.
    Yen, C. J.
    Lin, Y. L.
    Lin, Z. Z.
    Chen, L. T.
    Su, W. C.
    Chao, Y.
    Cheng, A. L.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S467 - S467
  • [2] Phase II Multicentered Study of Low-Dose Everolimus plus Cisplatin and Weekly 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin as First-Line Treatment for Patients with Advanced Gastric Cancer
    Shen, Ying-Chun
    Li, Chung-Pin
    Yen, Chia-Jui
    Hsu, Chiun
    Lin, Yu-Lin
    Lin, Zhong-Zhe
    Chen, Li-Tzong
    Su, Wu-Chou
    Chao, Yee
    Yeh, Kun-Huei
    Cheng, Ann-Lii
    ONCOLOGY, 2014, 87 (02) : 104 - 113
  • [3] Final results of first-line weekly paclitaxel plus gemcitabine in metastatic breast cancer (MBC): an AERO phase II trial
    Mousseau, M.
    Serin, D.
    Goubely-Brewer, Y.
    Petit, T.
    Priou, F.
    Zelek, L.
    BULLETIN DU CANCER, 2007, 94 (06) : 569 - 570
  • [4] Weekly one-hour paclitaxel as first-line chemotherapy for metastatic breast cancer
    Wist, EA
    Sommer, HH
    Ostenstad, B
    Risberg, T
    Fjæstad, K
    ACTA ONCOLOGICA, 2004, 43 (01) : 11 - 14
  • [5] PHASE II STUDY OF CETUXIMAB PLUS WEEKLY CISPLATIN AND 24-HOUR INFUSION OF HIGH-DOSE 5-FLUOROURACIL AND LEUCOVORIN FOR THE FIRST-LINE TREATMENT OF ADVANCED GASTRIC CANCER
    Yeh, K. H.
    Hsu, C. H.
    Hsu, C.
    Huang, C. L.
    Lin, C. H.
    Shen, Y. C.
    Wu, S. L.
    Chiou, T. J.
    Chao, Y.
    Cheng, A. L.
    ANNALS OF ONCOLOGY, 2008, 19 : 174 - 174
  • [6] Phase II study of cetuximab plus weekly cisplatin and 24-hour infusion of high-dose 5-fluorouracil and leucovorin for the first-line treatment of advanced gastric cancer
    Yeh, K.
    Hsu, C.
    Hsu, C.
    Lin, C.
    Shen, Y.
    Wu, S.
    Chiou, T.
    Chao, Y.
    Cheng, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [7] Results of first-line weekly paclitaxel (P) plus gemcitabine (G) in metastatic breast cancer (MBC): An AERO phase II trial
    Mousseau, M.
    Serin, D.
    Petit, T.
    Priou, F.
    Zelek, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] Phase II study of weekly low-dose everolimus plus weekly 24-hour infusions of cisplatin and high-dose 5-fluorouracil and leucovorin for first-line treatment in patients with advanced gastric cancers
    Yeh, K.
    Shen, Y.
    Li, C.
    Yen, C.
    Hsu, C.
    Lin, Z.
    Chen, L.
    Su, W.
    Chao, Y.
    Cheng, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [9] A randomized, phase II trial of weekly paclitaxel versus weekly paclitaxel plus carboplatin for first-line metastatic breast cancer.
    Robert, N
    Loesch, D
    Lindquist, D
    Ratnam, S
    Hyman, W
    Whittaker, T
    Logie, K
    Kruger, S
    Pippen, J
    Liu, L
    Goldstein, L
    Asmar, L
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S129 - S129
  • [10] Low-dose capecitabine plus docetaxel as first-line therapy for metastatic breast cancer: phase II results
    Michalaki, Vasiliki
    Gennatas, Spyridon
    Gennatas, Konstantine
    ANTI-CANCER DRUGS, 2009, 20 (03) : 204 - 207
12345